BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6274544)

  • 1. The metabolic effects of chronic hyperglucagonaemia.
    Nankervis A; Proietto J; Ng KW; Alford FP; Larkins R
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):325-33. PubMed ID: 6274544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
    Torre L; Vazquez JA; Blázquez E
    Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
    Kahn CR; Bhathena SJ; Recant L; Rivier J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma glucagon levels suppressed by a glucose load in a man with incidental pancreatic glucagonoma.
    Mai VQ; Jones RC; Dickert JM; Clyde PW; Shakir KM
    Endocr Pract; 2007; 13(7):780-4. PubMed ID: 18194937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
    Hendriks T; Jansen JB; van Tongeren JH
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and metabolic aspects of glucagonoma.
    Leichter SB
    Medicine (Baltimore); 1980 Mar; 59(2):100-13. PubMed ID: 6987481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of plasma adenosine 3',5'-monophosphate, blood glucose and plasma insulin to glucagon in humans.
    Søvik O; Heiervang E; Aksnes L; Selvig S
    Scand J Clin Lab Invest; 1981 Nov; 41(7):669-74. PubMed ID: 6280266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.
    Valverde I; Lemon HM; Kessinger A; Unger RH
    J Clin Endocrinol Metab; 1976 May; 42(5):804-8. PubMed ID: 178682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover.
    Kotzmann H; Linkesch M; Ludvik B; Clodi M; Luger A; Schernthaner G; Prager R; Klauser R
    Eur J Clin Invest; 1995 Dec; 25(12):942-7. PubMed ID: 8719935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma glucagon in insulinoma.
    Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
    Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucagonoma syndrome with normal blood glucagon ].
    Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
    Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin and glucagon in rats with islet cell tumors induced by small doses of streptozotocin.
    Yoshino G; Kazumi T; Morita S; Baba S
    Can J Physiol Pharmacol; 1981 Aug; 59(8):818-23. PubMed ID: 6271376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate.
    Lins PE; Efendić S
    Diabetes; 1979 Mar; 28(3):190-5. PubMed ID: 221293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucagonoma syndrome with a normal blood glucose curve].
    González de Zárate Apiñariz P; Alonso Alonso J; Vázquez García JA; Hernández Calvo J; Burgos Bretones J; Aguirre Errasti C; Díaz Pérez JL
    Med Clin (Barc); 1983 Oct; 81(9):396-8. PubMed ID: 6316044
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glucagonoma and somatostatinoma].
    Yoshida H; Shimizu N
    Nihon Rinsho; 1982 Feb; 40(2):441-5. PubMed ID: 6283209
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional studies in patients with the glucagonoma syndrome.
    Holst JJ; Helland S; Ingemannson S; Pedersen NB; von Schenck H
    Diabetologia; 1979 Sep; 17(3):151-6. PubMed ID: 510830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose turnover in insulinoma--a case report.
    Hanna AK; Vranic M; Zinman B
    Diabetes Res Clin Pract; 1987; 3(2):111-4. PubMed ID: 3032548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of glucagonoma].
    Numakawa T; Ikeuchi T; Sugimasa T; Inoue S; Takamura Y; Suda T
    Nihon Naika Gakkai Zasshi; 1982 Jul; 71(7):977-84. PubMed ID: 6294199
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucagonoma syndrome.
    Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.